Lanreotide acetate
CAS No. 2378114-72-6
Lanreotide acetate ( BIM 23014 (acetate) )
Catalog No. M21614 CAS No. 2378114-72-6
Lanreotide acetate is a somatostatin analogue with antineoplastic activity used for carcinoid syndrome.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 33 | Get Quote |
|
5MG | 53 | Get Quote |
|
10MG | 87 | Get Quote |
|
25MG | 158 | Get Quote |
|
50MG | 236 | Get Quote |
|
100MG | 350 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLanreotide acetate
-
NoteResearch use only not for human use.
-
Brief DescriptionLanreotide acetate is a somatostatin analogue with antineoplastic activity used for carcinoid syndrome.
-
DescriptionLanreotide acetate is a somatostatin analogue with antineoplastic activity used for carcinoid syndrome.
-
SynonymsBIM 23014 (acetate)
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Areacancer
-
IndicationMalignant Carcinoid Syndrome
Chemical Information
-
CAS Number2378114-72-6
-
Formula Weight1096.33
-
Molecular FormulaC54H69N11O10S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNA
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ning S et al. Lanreotide promotes apoptosis and is not radioprotective in GH3 cells.Endocr Relat Cancer.?2009 Sep;16(3):1045-55.
molnova catalog
related products
-
Sparteine
Sparteine is a natural product.
-
C75
C75 is an inhibitor synthetic fatty-acid synthase (FASN) and inhibits prostate cancer cells PC3 (IC50: 35 μM).
-
20-Hydroxyganoderic ...
20-Hydroxyganoderic acid G is a lanosterane triterpenoid obtained from the ethanolic extract of Ganoderma curtisii (Ganoderma curtisii) cotyledons.